2012
DOI: 10.1002/pbc.24421
|View full text |Cite
|
Sign up to set email alerts
|

Children's Oncology Group's 2013 blueprint for research: Behavioral science

Abstract: Behavioral science has long played a central role in pediatric oncology clinical service and research. Early work focused on symptom relief related to side effects of chemotherapy and pain management related to invasive medical procedures. As survival rates improved, the focused has shifted to examination of the psychosocial impact, during and after treatment, of pediatric cancer and its treatment on children and their families. The success of the clinical trials networks related to survivorship highlights an … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
32
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 38 publications
(33 citation statements)
references
References 67 publications
1
32
0
Order By: Relevance
“…According to the Children's Oncology Group's 2013 blueprint for research, over the next 5 years, the field of nursing and psychosocial science needs to translate empirical supported research into practice [3,23]. As most studies in this review are descriptive or comparative [32], this is not an easy task for clinical staff.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…According to the Children's Oncology Group's 2013 blueprint for research, over the next 5 years, the field of nursing and psychosocial science needs to translate empirical supported research into practice [3,23]. As most studies in this review are descriptive or comparative [32], this is not an easy task for clinical staff.…”
Section: Discussionmentioning
confidence: 99%
“…Early work focused on symptom relief, related to the side effects of chemotherapy, and pain management related to invasive medical procedures. As survival rates improved, the focus has shifted to descriptive studies examining the psychosocial impact on children and their families during and after treatment [3].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…This evaluation tool takes approximately 1 h to administer and is overseen by a psychologist. To date, several pediatric brain tumor trials including ACNS0331, ACNS0831 and ACNS1123 have incorporated ALTE07C1 as either a primary or secondary outcome [51]. The most notable barrier to ALTE07C1 compliance is the requirement of a psychologist for test administration.…”
Section: Neurocognitive Outcomesmentioning
confidence: 99%